Every Form 4 that Procter & Gamble Company (PG) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow PG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PG filings page.
PROCTER & GAMBLE Co (PG) insider Marc S. Pritchard, Chief Brand Officer, reported selling 4,030 shares of common stock on 2026-08-20 at $143.79 per share. A footnote states the shares were sold to cover taxes on a Stock Award. After the sale, he directly held 187,000.55 shares, with additional indirect holdings reported for his wife, three daughters, and retirement plan trustees.
PROCTER & GAMBLE Co (PG) reported that Juliana Monteiro Santos de Azevedo, CEO - Grooming, received equity awards in company stock. On 2026-08-19 she acquired 6,497 shares of Common Stock at $0.00 per share under the 2025 Stock and Incentive Compensation Plan, bringing her direct Common Stock holdings to 25,969.2363 shares, which include dividend equivalents and shares from the dividend reinvestment plan. She also holds indirect Common Stock positions of 163.6046 shares through a retirement plan trustee and 331.2100 shares through an International Stock Ownership Plan & Pension Plan. On 2026-08-17 she was granted 12.072 Restricted Stock Units tied to Common Stock as dividend equivalents under a retirement program, increasing her direct RSU balance to 85.4781 units, which will be delivered in shares upon retirement or as otherwise deferred or contributed to a deferred compensation account.
PROCTER & GAMBLE Co (symbol: PG) is the issuer of record for a Form 4 filing submitted to the SEC.
PROCTER & GAMBLE Co (symbol: PG) is the issuer of record for a Form 4 filing submitted to the SEC.
PROCTER & GAMBLE Co (PG) reported that its Chief Human Resources Officer, the reporting person in this Form 4, received equity-based compensation. On 2026-08-19, the reporting person was granted 4,787 shares of Common Stock at $0.00 per share under the 2025 Stock and Incentive Compensation Plan, including dividend equivalents in the form of RSUs settled in common stock. Following this grant, the reporting person directly holds 17,495.7953 shares of Common Stock and indirectly holds 5,820.1949 shares through a retirement plan trustee.
Separately, on 2026-08-17, the reporting person acquired 11.107 Restricted Stock Units as dividend equivalents under the issuer’s retirement program, each representing a contingent right to receive one share of Procter & Gamble common stock. After this transaction, the reporting person holds 71.3615 RSUs, which will deliver in shares upon retirement, subject to any deferral or contribution to a deferred compensation account.
PROCTER & GAMBLE Co (PG) reported that Chairman, President and CEO Shailesh Jejurikar received equity awards. On 2026-08-19 he acquired 16,195 shares of common stock at $0.00 per share as a stock award under the 2025 Stock and Incentive Compensation Plan, bringing his directly held common stock to 45,501.9973 shares. On 2026-08-17 he also received 45.2221 Restricted Stock Units as dividend equivalents under the retirement program, increasing his directly held RSUs to 734.2684 units, each representing a contingent right to common stock. Additional indirect holdings are reported through a retirement plan and two personal trusts.
PROCTER & GAMBLE Co (PG) reported that Freddy P. Bharucha, CEO – Beauty, received equity-based compensation and updated his share holdings. On 2026-08-19 he was granted 837 shares of Common Stock at $0.00 per share as a stock award under the company’s 2025 Stock and Incentive Compensation Plan, including dividend equivalents in the form of Restricted Stock Units settled in common stock. Following this grant, his directly held common shares total 2,211.4595. Indirect holdings include 5,623.1557 shares held by a retirement plan trustee and 398.4500 shares held by his spouse, which include shares acquired through Procter & Gamble’s dividend reinvestment plan, plus additional indirect positions through spouse and plan-related accounts. On 2026-08-17 he also acquired 7.2812 Restricted Stock Units, bringing his total RSUs under the issuer’s retirement program to 36.8215, each representing a contingent right to receive Procter & Gamble common stock, deliverable in shares upon retirement unless deferred or contributed to a deferred compensation account.
PROCTER & GAMBLE Co (PG) reported that officer Moses Victor Javier Aguilar received a grant of 6,839 shares of Common Stock on 2026-08-19 at $0.00 per share, as a stock award under the 2025 Stock and Incentive Compensation Plan. After this award, he holds 52,564.0935 shares of common stock directly, which include dividend equivalents granted as Restricted Stock Units and shares acquired through the dividend reinvestment plan. He also holds 7,476.1294 shares indirectly through a retirement plan trustee and 428.6033 shares through an International Stock Ownership Plan trustee. In addition, on 2026-08-17 he received 20.6886 Restricted Stock Units, bringing his RSU balance to 189.4214 units, each representing a contingent right to receive Procter & Gamble common stock, generally deliverable in shares upon retirement or as otherwise deferred.
PROCTER & GAMBLE Co (PG) reported that Hesham Abd El Hak, CEO-Baby and Feminine Care, received a grant of 5,129 shares of Common Stock on 2026-08-19 at a stated price of $0.00 per share, under the 2025 Stock and Incentive Compensation Plan. Following this award, he directly holds 13,153.9294 Common shares, which include dividend equivalents in the form of RSUs settled in stock and shares acquired through the dividend reinvestment plan. He also holds Common Stock indirectly through a retirement plan trustee and an international stock ownership and pension plan. In addition, on 2026-08-17 he acquired 5.2953 Restricted Stock Units, bringing his total directly held RSUs to 42.5303 units, representing contingent rights to receive PG common stock, generally deliverable in shares at retirement or as otherwise deferred.
PROCTER & GAMBLE Co (symbol: PG) is the issuer of record for a Form 4 filing submitted to the SEC.
PROCTER & GAMBLE Co (PG) reported that officer Paul Gama, CEO-Health Care, received 7,727 shares of Common Stock on 2026-08-19 as a stock award under the 2025 Stock and Incentive Compensation Plan, bringing his directly held common shares to 44,227.8803.
He also acquired 7.0954 Restricted Stock Units as dividend equivalents tied to the retirement program, increasing his RSU balance to 72.6299 units, which will deliver in common shares at retirement (subject to possible deferral or contribution to a deferred compensation account). In addition, 1,173.4717 shares are held indirectly through a retirement plan trustee.
PROCTER & GAMBLE Co (PG) reported that its Chief Brand Officer, as reporting person, received equity awards and updated holdings. On 2026-08-19, the officer acquired 7,857 shares of common stock as a stock award under the 2025 Stock and Incentive Compensation Plan, bringing directly held common shares to 191,030.55, including dividend-equivalent RSUs settled in stock. On 2026-08-17, the officer was granted 276.4492 Restricted Stock Units tied to Procter & Gamble common stock under a retirement program, with delivery in shares upon retirement or deferral. The filing also reports indirect common stock holdings through the officer’s daughters, retirement plan trustees, and spouse.
PROCTER & GAMBLE Co (PG) reported insider equity activity by Chief Legal Officer & Secy Susan Street Whaley. On 2026-08-18, she sold 8,644 shares of common stock at $144.00 per share. On 2026-08-19, she received a stock award of 7,371 shares of common stock under the 2025 Stock and Incentive Compensation Plan. On 2026-08-17, she was granted 13.4479 Restricted Stock Units, representing dividend equivalents under a retirement program that will be delivered in common shares upon retirement or as otherwise deferred. An indirect retirement plan holding shows 7,187.9174 shares of common stock.
Bharucha Freddy P. reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co executive Freddy P. Bharucha, CEO – Beauty, reported multiple equity awards and updated holdings. On 2026-08-06 he received a retirement award of 789 Restricted Stock Units, each representing a contingent right to P&G common stock or cash per a plan formula for the year ended 6/30/2026. Earlier in 2026 he also received smaller RSU dividend-equivalent awards and Series A Preferred Stock awards tied to retirement plans, all at a stated price of $0.0000 per unit. Following these transactions, reported common stock holdings include 1,364.1458 shares held directly and additional indirect holdings through retirement plans and by spouse.
Jejurikar Shailesh reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co Chairman, President and CEO Shailesh Jejurikar reported multiple equity awards and updated holdings. On 2026-08-06 he received 947 Restricted Stock Units as a retirement award, representing a contingent right to P&G common stock or cash, with amount and price computed under a benefit formula for the plan year ended 6/30/2026. Earlier in 2026 he also received smaller dividend-equivalent RSU awards and a Series A preferred stock award tied to retirement plan activity. Following these transactions, reported holdings include 29,129.4167 common shares held directly and additional indirect holdings through a retirement plan trustee and personal trusts.
Abd El Hak Hesham reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co executive Hesham Abd El Hak, CEO-Baby and Feminine Care, reported equity awards and updated holdings. On 2026-08-06 he received a retirement award of 284 Restricted Stock Units, representing a contingent right to P&G common stock or cash, computed under a benefit formula for the plan year ended 6/30/2026. These units are scheduled to deliver in shares upon retirement, subject to possible deferral or contribution to a deferred compensation account. He also reported an earlier 2026-07-14 grant of 0.1438 shares of Series A Preferred Stock held by a retirement plan trustee, convertible or redeemable into common stock under specified plan conditions.
Following these transactions, he directly holds 7,964.4034 shares of common stock, plus indirect holdings of 1,528.8968 shares through a retirement plan trustee and 43.95 shares through an international stock ownership and pension plan. The Form indicates no transactions under a Rule 10b5-1 trading plan.
Aguilar Moses Victor Javier reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co executive Moses Victor Javier Aguilar, Chief Research, Development & Innovation Officer, reported multiple equity-based awards and updated share holdings. On 2026-08-06 he received 857 Restricted Stock Units that will deliver in common shares on retirement or as deferred compensation. He also reported total direct common stock holdings of 45,378.0271 shares, plus indirect holdings of 7,476.1294 shares through a retirement plan trustee and 428.6033 shares through an international stock ownership plan. Earlier awards included 20.6650 and 17.6690 RSUs as dividend equivalents under the retirement program and a small 0.3148 share Series A preferred stock award linked to the retirement plan.
PROCTER & GAMBLE Co executive Paul Gama, CEO–Health Care, reported grants and plan-related awards rather than open-market trading. On 2026-08-06 he received 272 Restricted Stock Units as a retirement award that may settle in P&G common stock or cash, calculated under a benefit formula for the plan year ended 6/30/2026. Earlier, on 2026-05-15 he received 7.0873 RSUs as dividend equivalents under the issuer’s retirement program, each representing a contingent right to common stock. A retirement plan also acquired 0.1051 shares of Series A Preferred Stock on 2026-07-14, indirectly held by a Retirement Plan Trustee and ultimately convertible into common stock under specified conditions. Following these updates, Gama holds 36,225.5685 common shares directly (including RSU dividend equivalents settled in stock) and 1,173.4717 common shares indirectly plus 221.7431 shares of Series A Preferred Stock through the retirement plan trustees.
PROCTER & GAMBLE Co executive Juliana Monteiro Santos de Azevedo, CEO - Grooming, received a retirement award of 481 Restricted Stock Units on August 6, 2026. These RSUs represent a contingent right to receive P&G common stock or cash, computed under a benefit formula for the plan year ended June 30, 2026, and will be delivered in shares upon retirement, subject to possible deferral or contribution to a deferred compensation account.
She also acquired 0.0872 shares of Series A Preferred Stock on July 14, 2026, held indirectly by Retirement Plan Trustees and convertible or redeemable into common stock at a specified conversion or exercise price. Following these entries, she holds 19,361.8513 common shares directly and additional indirect holdings through retirement and international stock ownership and pension plans.
Schulten Andre reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co Chief Financial Officer Andre Schulten reported multiple equity awards and updated holdings. On August 6, 2026, he received 1,375 Restricted Stock Units as a retirement award, each representing a contingent right to Procter & Gamble common stock or cash settlement under a benefit formula for the plan year ended June 30, 2026.
Additional dividend-equivalent RSUs tied to the issuer’s retirement program were credited on May 15 and February 17, 2026. Indirectly, 0.3148 shares of Series A Preferred Stock were granted through a retirement plan trustee, convertible into common stock at the higher of $6.82 or market price. Following these updates, direct common stock holdings are 53,731.0367 shares, with 7,535.1091 shares held indirectly by a retirement plan trustee. No sales or dispositions were reported.
Whaley Susan Street reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co executive Susan Street Whaley, Chief Legal Officer & Secretary, reported equity-based awards rather than open-market trades. On August 6, 2026, she received 895 Restricted Stock Units as a retirement award and 13.4324 RSUs as dividend equivalents, each representing contingent rights to P&G common stock that generally deliver in shares upon retirement or as otherwise deferred. She also holds 30,357.4176 shares of common stock directly and 7,187.9174 shares indirectly through a retirement plan, plus 1,532.6805 shares of Series A Preferred Stock held by retirement plan trustees, which are convertible or redeemable based on a formula including the higher of $6.82 or the market price of the common stock.
Raman Sundar G. reported acquisition or exercise transactions in this Form 4 filing.
Procter & Gamble Co executive Sundar G. Raman, CEO-Fabric Home & Habitat Care, reported multiple equity compensation awards and updated holdings. On 2026-08-06 he received 1,222 Restricted Stock Units as a retirement award, each representing a contingent right to P&G common stock or cash settlement. Additional RSU dividend-equivalent awards of 33.577 and 28.7092 units were granted earlier in 2026 under the retirement program, all scheduled to deliver in shares upon retirement or as otherwise elected. A separate retirement-plan award of 0.3148 shares of Series A Preferred Stock, convertible into common stock, increased his retirement-plan preferred position. Following these entries, reported holdings include 41,892.6366 common shares held directly and 9,145.8364 common shares (including related equivalents) held indirectly through a retirement plan trustee.
Purushothaman Balaji reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co executive Purushothaman Balaji, Chief Human Resources Officer, reported awards and holdings of company equity. On 2026-08-06, he received 800 Restricted Stock Units that deliver in shares at retirement or may be deferred or contributed to a deferred compensation account. Earlier in 2026 he also received smaller RSU awards and dividend-equivalent RSUs under the issuer’s retirement program. Direct common stock holdings total 12,684.2607 shares, including grants of dividend equivalents settled in common stock, and additional common and Series A preferred shares are held indirectly by Retirement Plan Trustees for his benefit.
Procter & Gamble Chief Brand Officer Marc S. Pritchard reported several equity compensation awards and updated holdings. On 2026-08-06 he received 1,307 Restricted Stock Units as a retirement-related award, each representing a contingent right to receive Procter & Gamble common stock or cash, with delivery generally upon retirement. Earlier, he was granted 276.1342 RSUs on 2026-05-15 and 236.1005 RSUs on 2026-02-17 as dividend-equivalent awards under the issuer’s retirement program. He also acquired 0.3148 shares of Series A Preferred Stock on 2026-07-14 through retirement plan trustees, with that preferred stock convertible or redeemable into common stock at the higher of $6.82 (split-adjusted) or the market price, in connection with plan distribution or investment elections. Following these updates, reported direct common stock holdings are 182,974.8053 shares, with additional indirect holdings including 49,633.6507 common shares and 12,512.9938 preferred shares held by retirement plan trustees, and smaller indirect positions held by his spouse and three daughters.
Janzaruk Matthew W. reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co executive Matthew W. Janzaruk, SVP and Chief Accounting Officer, received an award of 278 Restricted Stock Units of common stock on August 6, 2026 under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. Including dividend-equivalent RSUs, his directly held common stock increased to 1,263.7766 shares. Separately, retirement plan holdings were updated to 3,888.7974 shares of common stock and 1,929.3975 shares of Series A Preferred Stock, which is convertible into common stock at the higher of $6.82 or the market price upon certain distribution or investment elections.
Procter & Gamble Co reporting person Jon R. Moeller, Retired Chairman, received several equity-based awards and updated his holdings. On August 6, 2026 he acquired 1,936 Restricted Stock Units as a retirement award, each representing a contingent right to receive Procter & Gamble common stock or cash. Earlier in 2026 he also acquired 261.2045 and 223.3356 RSUs as dividend equivalents under the retirement program, and on July 14, 2026 he acquired 0.3148 shares of Series A Preferred Stock through Retirement Plan Trustees. Following these updates, he holds 320,016.5122 common shares directly, plus additional indirect holdings through Retirement Plan Trustees and his spouse.
PROCTER & GAMBLE Co director Robert Jones Portman received 51 shares of common stock as a stock award. The award was reported at a price of $0.00 per share and represents Restricted Stock Units granted under The Procter & Gamble 2025 Stock and Incentive Compensation Plan.
Footnotes state the total reported amount includes dividend equivalents granted in the form of additional Restricted Stock Units. After this compensation-related acquisition, Portman’s directly held position increased to about 5,155.4641 shares, reflecting a routine equity grant rather than an open-market purchase.
McEvoy Ashley reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co director Ashley McEvoy received an equity award of 202 shares of Common Stock-equivalent Restricted Stock Units. The award was granted at no cash cost under The Procter & Gamble 2025 Stock and Incentive Compensation Plan and includes dividend equivalents paid in additional Restricted Stock Units. Following this grant, McEvoy directly holds a total of 5,986.2484 shares of Procter & Gamble common stock, reflecting a routine compensation-related increase in equity ownership rather than an open-market purchase.
PROCTER & GAMBLE Co director receives equity award through a grant of 253 shares of common stock on June 9, 2026, reported as a grant, award, or other acquisition at a stated price of $0.00 per share. The award represents Restricted Stock Units granted under The Procter & Gamble 2025 Stock and Incentive Compensation Plan, including dividend equivalents in the form of additional Restricted Stock Units. Following this compensation-related grant, Christine M. McCarthy directly holds a total of 17,512.6591 shares of Procter & Gamble common stock.
PROCTER & GAMBLE Co director Christopher J. Kempczinski reported an equity award on a Form 4. On June 9, 2026, he acquired 258 Restricted Stock Units at $0.00 per unit under The Procter & Gamble 2025 Stock and Incentive Compensation Plan, including dividend equivalents, bringing his reported holdings to 11,595.5466 shares/units.
JIMENEZ JOSEPH reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co director Joseph Jimenez reported receiving an award of 320 shares of Common Stock in the form of Restricted Stock Units under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. The award was granted at no cash price as part of his equity compensation.
After this grant, Jimenez directly holds a total of 37,016.0703 shares of Common Stock, including prior awards and dividend equivalents credited in Restricted Stock Units.
ARNOLD CRAIG reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co director Craig Arnold received an award of 202 shares of common stock in the form of Restricted Stock Units on 2026-06-09. The grant was made at $0.00 per share as part of The Procter & Gamble 2025 Stock and Incentive Compensation Plan and includes dividend equivalents in additional RSUs.
After this compensation award, Arnold directly holds a total of 2,807.8441 shares. This is a routine equity grant rather than an open-market purchase or sale, and there are no remaining derivative positions disclosed in this filing.
PROCTER & GAMBLE Co director Portman Robert Jones reported an amended equity award. The Form 4/A corrects a prior filing that had shown a grant of 193 restricted stock units under the company’s 2025 Stock and Incentive Compensation Plan; the amended report shows an award of 49 RSUs instead. Following this compensation-related acquisition, his directly held common stock position is 5,065.7148 shares, making the change administrative rather than a new trading decision.
Portman Robert Jones reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co director Robert Jones Portman received an equity award of 193 shares of Common Stock on 2026-03-10.
The award consists of Restricted Stock Units granted under The Procter & Gamble 2025 Stock and Incentive Compensation Plan, including dividend equivalents in the form of additional units. Following this grant, he holds 5,209.7148 shares directly.
McEvoy Ashley reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co director Ashley McEvoy received an equity award of 161 shares of Common Stock on 2026-03-10. The transaction is coded as a grant or award, not an open-market purchase, with a price per share of $0.0000, indicating compensation rather than cash investment.
Footnotes explain that the award consists of Restricted Stock Units granted under The Procter & Gamble 2025 Stock and Incentive Compensation Plan, and that the total includes dividend equivalents in the form of additional Restricted Stock Units. Following this grant, McEvoy directly holds 5,751.065 shares.
McCarthy Christine M reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co director Christine M. McCarthy received an award of 209 shares of Common Stock on March 10, 2026. The filing describes this as a grant or award transaction, with no cash price per share reported.
These shares are in the form of Restricted Stock Units granted under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. The total reported direct holdings after this award are 17,128.6365 shares, which include dividend equivalents granted as additional Restricted Stock Units.
Kempczinski Christopher J reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co director Christopher J. Kempczinski received an award of 201 shares of Common Stock as a grant under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. After this compensation-related award, his directly held stake increased to 11,251.4805 shares, including dividend-equivalent restricted stock units.
JIMENEZ JOSEPH reported acquisition or exercise transactions in this Form 4 filing.
PROCTER & GAMBLE Co director Joseph Jimenez received a grant of 273 shares of Common Stock in the form of restricted stock units. The award was made at no cash price as part of The Procter & Gamble 2025 Stock and Incentive Compensation Plan and includes dividend equivalents credited as additional units. After this compensation-related grant, his directly held position reported in this filing increased to 36,512.1482 shares of Common Stock, showing this is a relatively small, routine addition to an existing stake rather than a market purchase or sale.
ARNOLD CRAIG reported acquisition or exercise transactions in this Form 4 filing.
Procter & Gamble director Craig Arnold received a grant of 161 shares of Common Stock through Restricted Stock Units under The Procter & Gamble 2025 Stock and Incentive Compensation Plan. The award, which includes dividend equivalents in the form of additional Restricted Stock Units, increased his directly held position to 2,586.0624 shares.
PROCTER & GAMBLE Co executive Francisco Ma. Fatima, CEO of Baby, Fem & Family Care, reported multiple stock moves. On February 27, 2026, she completed open-market sales totaling 5,549 shares of common stock at prices around $165.29 to $165.32, leaving 1,028.739 directly held shares.
She also received a grant of 57.0033 Restricted Stock Units on February 17, 2026, bringing her direct RSU holdings to 888.7607 units. Footnotes explain these RSUs include dividend equivalents that will deliver in shares at retirement or as deferred compensation. Additional indirect common stock holdings are reported through retirement plans, a spouse, and a SLAT trust.
PROCTER & GAMBLE Co executive Susan Street Whaley reported both a stock sale and an equity award. On February 19, 2026, she completed an open-market sale of 1,809 shares of common stock at an average price of $159.4551 per share.
After this sale, her directly held common stock position was 30,215.0293 shares. She also had 6,589.6417 shares held indirectly through a retirement plan trustee. On February 17, 2026, she acquired 11.485 restricted stock units at no cost, increasing her RSU balance to 65.1290 units, which are scheduled to settle in Procter & Gamble common stock, generally in connection with retirement.
Procter & Gamble's Chief Research, Development & Innovation Officer, Aguilar Moses Victor Javier, exercised stock options and sold shares on February 13, 2026. He exercised 15,169 stock options at an exercise price of $91.07 per share, receiving the same number of common shares.
On the same day, he sold 15,169 common shares in an open-market transaction at a weighted average price of $162.2789 per share, within a price range of $162.26 to $162.311. Following these transactions, he held 44,735.4826 common shares directly, plus additional indirect holdings through a retirement plan and an international stock ownership plan.
Procter & Gamble’s Chief Human Resources Officer, Purushothaman Balaji, reported an option exercise and share sale on February 11, 2026. He exercised a stock option for 12,827 shares of common stock at an exercise price of $91.07 per share.
On the same day, he sold 12,827 common shares in an open-market transaction at a weighted average price of $160.3093 per share, as disclosed in the footnote. Following these transactions, he held 12,638.8004 shares directly and 5,223.363 shares indirectly through a retirement plan trustee.
Procter & Gamble executive chair Jon R. Moeller, who also serves as a director, reported option exercises and share sales in February 2026. On February 11, he exercised options for 11,036 common shares at $113.23 and sold 11,036 shares at $160. On February 12, he exercised options for 162,232 shares at $113.23 and sold 162,232 shares at a weighted average price of $162.4486. After these transactions, he directly holds 319,384.99 common shares, plus indirect holdings of 25,001.0511 shares through retirement plan trustees and 35,421.5707 shares held by his spouse.
Procter & Gamble CEO – Grooming Gary A. Coombe reported multiple equity transactions in Procter & Gamble common stock. On February 12, 2026, he exercised stock options for 36,093 shares at an exercise price of $78.52 per share, receiving the same number of common shares.
On the same date, he then sold 36,093 common shares in open-market transactions at a weighted average price of $162.3307, leaving 34,993.7893 shares of directly held common stock. He also reports indirect holdings of 486.4342 shares through a retirement plan trustee and 1,295.35 shares through an international stock ownership and pension plan.
In addition, previously granted restricted stock units, including 63.6893 units awarded on November 17, 2025, total 1,117.3663 RSUs. Footnotes explain that these RSUs and some share totals include dividend equivalents and may be delivered in shares upon retirement under the company’s programs.
Procter & Gamble executive Ma. Fatima Francisco, CEO of the Baby, Fem & Family Care unit, reported a sale of 8,000 shares of common stock on 02/04/2026 at $158 per share. After this sale, she directly holds 6,571.1998 shares of P&G common stock.
She also reports indirect holdings of 16,139.3909 shares through a retirement plan trustee, 2,898.8166 shares held by her spouse and retirement plan trustees, and 12,731 shares held by a SLAT. A footnote states one position reflects an adjustment to PST through December 31, 2025.
Procter & Gamble Chief Brand Officer Marc S. Pritchard reported an option exercise and share sale in Procter & Gamble common stock on January 23, 2026. He exercised a stock option for 95,903 shares at an exercise price of $80.29 per share, then sold 95,903 shares of common stock at a weighted average price of $151.1495 per share, within a price range of $150.36 to $151.60. Following these transactions, he directly owned 182,606.5502 shares of Procter & Gamble common stock, with additional indirect holdings through his daughters, retirement plan trustees, and his wife.
Procter & Gamble (PG) director Robert Portman reported a small equity compensation grant. On 12/09/2025, he acquired 54 shares of Procter & Gamble common stock through restricted stock units at a price of $0, reflecting a stock-based award rather than an open-market purchase.
The award was granted under The Procter & Gamble 2025 Stock and Incentive Compensation Plan and includes dividend equivalents in the form of additional restricted stock units. Following this transaction, Portman beneficially owns 4,983.9036 shares of Procter & Gamble common stock in direct ownership.
Procter & Gamble director reports stock award under compensation plan. A company director received an award of 215 shares of Procter & Gamble common stock on 12/09/2025, recorded at a price of $0 per share. The award was granted under The Procter & Gamble 2025 Stock and Incentive Compensation Plan.
Following this grant, the director directly beneficially owns 5,562.7456 shares of common stock. This total includes dividend equivalents that were granted in the form of restricted stock units, so it reflects both shares and related stock-based incentives.
Procter & Gamble reported an insider equity award for director Christine M. McCarthy on Form 4. On 12/09/2025, she received 269 shares of Procter & Gamble common stock in the form of Restricted Stock Units, shown at a price of $0 per unit because they are part of her compensation rather than an open-market purchase. These units were granted under The Procter & Gamble 2025 Stock and Incentive Compensation Plan, and her total beneficial ownership after this award is 16,808.9761 shares.
The total ownership figure also includes dividend equivalents that are credited as additional Restricted Stock Units, which means her position can gradually grow as dividends are paid. This filing reflects routine equity compensation for a board member, rather than a large discretionary buy or sale in the market.